1 of 1
Story summary
- Marty Makary, commissioner of the U.S. Food and Drug Administration, defended the agency's stance on mRNA vaccines at a February 23, 2026 event.
- He said the FDA supports mRNA technology.
- Taxpayers should not finance its development.
- Makary criticized the Department of Health and Human Services for cutting over $700 million in mRNA funding and noted two vaccines for respiratory syncytial virus (RSV) showing potential for cancer treatment.
